P133: CNS hemangioblastoma in pediatric patients with von Hippel–Lindau disease: When to start surveillance*

• Yoshiko Nakano,
• Bailey Gallinger,
• Rosemarie Vnier,
• Abhaya Kulkarni,
• Peter Dirks,
• James Rutka,
• Jonathan Wasserman,
• Anita Villani,
• David Malkin

Affiliations

Yoshiko Nakano

Division of Haematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto

Bailey Gallinger

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Department of Molecular Genetics, University of Toronto

Rosemarie Vnier

Genetics and Genome Biology Program, The Hospital for Sick Children

Abhaya Kulkarni

Division of Neurosurgery, The Hospital for Sick Children

Peter Dirks

Division of Neurosurgery, The Hospital for Sick Children

James Rutka

Division of Neurosurgery, The Hospital for Sick Children

Jonathan Wasserman

Division of Endocrinology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto

Anita Villani

Division of Haematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto

David Malkin

Division of Haematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto